Weiss Multi-Strategy Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,000	Closed	-$256K	–	839
2020 Q3	$256K	Sell	18,000 -2,000	-10%	-$30.6K	0.01%	519
2020 Q2	$294K	Sell	20,000 -21,761	-52%	-$221K	0.01%	496
2020 Q1	$172K	Sell	41,761 -48,239	-54%	-$226K	0.01%	392
2019 Q4	$433K	Hold	90,000	–	–	0.01%	542
2019 Q3	$545K	Sell	90,000 -20,000	-18%	-$125K	0.01%	485
2019 Q2	$714K	Sell	110,000 -20,000	-15%	-$141K	0.02%	405
2019 Q1	$922K	Sell	130,000 -526	-0.4%	-$3.46K	0.02%	404
2018 Q4	$634K	Hold	130,526	–	–	0.03%	335
2018 Q3	$959K	Sell	130,526 -39,474	-23%	-$290K	0.03%	399
2018 Q2	$1.08M	Sell	170,000 -30,000	-15%	-$198K	0.03%	430
2018 Q1	$1.09M	Buy	200,000 +49,000	+32%	+$244K	0.03%	410
2017 Q4	$630K	Buy	151,000 +58,000	+62%	+$349K	0.02%	478
2017 Q3	$896K	Buy	93,000 +2,000	+2%	+$20.8K	0.03%	388
2017 Q2	$1.08M	Buy	91,000 +21,000	+30%	+$268K	0.05%	348
2017 Q1	$897K	Hold	70,000	–	–	0.04%	397
2016 Q4	$857K	Buy	70,000 +1,000	+1%	+$11.9K	0.04%	289
2016 Q3	$814K	Sell	69,000 -3,900	-5%	-$37.6K	0.05%	309
2016 Q2	$634K	Sell	72,900 -52,100	-42%	-$357K	0.05%	298
2016 Q1	$659K	Buy	125,000 +25,000	+25%	+$139K	0.03%	370
2015 Q4	$776K	Buy	100,000 +29,000	+41%	+$223K	0.05%	265
2015 Q3	$559K	Buy	71,000 +1,000	+1%	+$9.25K	0.02%	313
2015 Q2	$634K	Buy	70,000 +500	+0.7%	+$5.04K	0.03%	360
2015 Q1	$902K	Sell	69,500 -5,500	-7%	-$71.9K	0.04%	329
2014 Q4	$1.02M	Sell	75,000 -20,000	-21%	-$224K	0.04%	281
2014 Q3	$852K	Sell	95,000 -5,000	-5%	-$53.8K	0.02%	394
2014 Q2	$1.35M	Hold	100,000	–	–	0.03%	380
2014 Q1	$994K	Sell	100,000 -25,000	-20%	-$311K	0.02%	480
2013 Q4	$1.66M	Buy	125,000 +35,000	+39%	+$425K	0.04%	356
2013 Q3	$1.09M	Buy	+90,000	New	+$965K	0.02%	399

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GNMK Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 18,000 shares — an estimated $256K sold.

Weiss Multi-Strategy Advisers first reported a position in GNMK in Q3 2013 and held it in 29 quarters. The position peaked at $1.66M in Q4 2013. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 18,000 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $256K.
Weiss Multi-Strategy Advisers first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 29 quarters.
Weiss Multi-Strategy Advisers's GenMark Diagnostics, Inc position peaked at $1.66M in Q4 2013.
151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.